 |
The Journal of Neuroscience, November 26, 2003, 23(34):10934-10943
Previous Article | Next Article 
Cellular/Molecular
Neurosteroids Shift Partial Agonist Activation of GABAA Receptor Channels from Low- to High-Efficacy Gating Patterns
Matt T. Bianchi1 and
Robert L. Macdonald2
1Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan 48104-1687, and 2Departments of Neurology, Molecular Physiology and Biophysics, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37212
Although GABA activates synaptic (  ) GABAA receptors with high efficacy, partial agonist activation of   isoforms and GABA activation of the primary extrasynaptic (  ) GABAA receptors are limited to low-efficacy activity, characterized by minimal desensitization and brief openings. The unusual sensitivity of   receptor channels to neurosteroid modulation prompted investigation of whether this high sensitivity was dependent on the subunit or the low-efficacy channel function that it confers. We show that the isoform specificity (  >   ) of neurosteroid modulation could be reversed by conditions that reversed isoform-specific activity modes, including the use of -alanine to achieve increased efficacy with   receptors and taurine to render   receptors low efficacy. We suggest that neurosteroids preferentially enhance low-efficacy GABAA receptor activity independent of subunit composition. Allosteric conversion of partial to full agonism may be a general mechanism for reversibly scaling the efficacy of GABAA receptors to endogenous partial agonists.
Key words: GABAA receptor; neurosteroid; modal gating; desensitization; subunit; taurine; -alanine
Received July 23, 2003;
revised September 12, 2003;
accepted September 22, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
D. Belelli, N. L. Harrison, J. Maguire, R. L. Macdonald, M. C. Walker, and D. W. Cope
Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function
J. Neurosci.,
October 14, 2009;
29(41):
12757 - 12763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. O'Shea, C. A. Williams, and A. Jenkins
Inverse Effects on Gating and Modulation Caused by a Mutation in the M2-M3 Linker of the GABAA Receptor {gamma} Subunit
Mol. Pharmacol.,
September 1, 2009;
76(3):
641 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-Z. Zhan and J. V. Nadler
Enhanced Tonic GABA Current in Normotopic and Hilar Ectopic Dentate Granule Cells After Pilocarpine-Induced Status Epilepticus
J Neurophysiol,
August 1, 2009;
102(2):
670 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Maldonado-Aviles, A. A. Curley, T. Hashimoto, A. L. Morrow, A. J. Ramsey, P. O'Donnell, D. W. Volk, and D. A. Lewis
Altered Markers of Tonic Inhibition in the Dorsolateral Prefrontal Cortex of Subjects With Schizophrenia
Am J Psychiatry,
April 1, 2009;
166(4):
450 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Kaur, R. Baur, and E. Sigel
Unanticipated Structural and Functional Properties of {delta}-Subunit-containing GABAA Receptors
J. Biol. Chem.,
March 20, 2009;
284(12):
7889 - 7896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Stewart, R. Desai, Q. Cheng, A. Liu, and S. A. Forman
Tryptophan Mutations at Azi-Etomidate Photo-Incorporation Sites on {alpha}1 or {beta}2 Subunits Enhance GABAA Receptor Gating and Reduce Etomidate Modulation
Mol. Pharmacol.,
December 1, 2008;
74(6):
1687 - 1695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jia, M. Yue, D. Chandra, A. Keramidas, P. A. Goldstein, G. E. Homanics, and N. L. Harrison
Taurine Is a Potent Activator of Extrasynaptic GABAA Receptors in the Thalamus
J. Neurosci.,
January 2, 2008;
28(1):
106 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mizokami, T. Kanematsu, H. Ishibashi, T. Yamaguchi, I. Tanida, K. Takenaka, K. I. Nakayama, K. Fukami, T. Takenawa, E. Kominami, et al.
Phosholipase C-Related Inactive Protein Is Involved in Trafficking of {gamma}2 Subunit-Containing GABAA Receptors to the Cell Surface
J. Neurosci.,
February 14, 2007;
27(7):
1692 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Akk, P. Li, B. D. Manion, A. S. Evers, and J. H. Steinbach
Ethanol Modulates the Interaction of the Endogenous Neurosteroid Allopregnanolone with the {alpha}1beta2{gamma}2L GABAA Receptor
Mol. Pharmacol.,
February 1, 2007;
71(2):
461 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Drafts and J. L. Fisher
Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
1094 - 1101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. C. Lema and A. Auerbach
Modes and models of GABAA receptor gating
J. Physiol.,
April 1, 2006;
572(1):
183 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Chernova, D. H. Vandorpe, J. S. Clark, J. I. Williams, M. A. Zasloff, L. Jiang, and S. L. Alper
Apparent receptor-mediated activation of Ca2+-dependent conductive Cl- transport by shark-derived polyaminosterols
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2005;
289(6):
R1644 - R1658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Feng and R. L. Macdonald
Multiple Actions of Propofol on {alpha}{beta}{gamma} and {alpha}{beta}{delta} GABAA Receptors
Mol. Pharmacol.,
December 1, 2004;
66(6):
1517 - 1524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L Fisher
The {alpha}1 and {alpha}6 subunit subtypes of the mammalian GABAA receptor confer distinct channel gating kinetics
J. Physiol.,
December 1, 2004;
561(2):
433 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Feng, M. T. Bianchi, and R. L. Macdonald
Pentobarbital Differentially Modulates {alpha}1{beta}3{delta} and {alpha}1{beta}3{gamma}2L GABAA Receptor Currents
Mol. Pharmacol.,
October 1, 2004;
66(4):
988 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Feng and R. L. Macdonald
Proton Modulation of {alpha}1{beta}3{delta} GABAA Receptor Channel Gating and Desensitization
J Neurophysiol,
September 1, 2004;
92(3):
1577 - 1585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liang, E. Cagetti, R. W. Olsen, and I. Spigelman
Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
1234 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Akk, J. R. Bracamontes, D. F. Covey, A. Evers, T. Dao, and J. H. Steinbach
Neuroactive steroids have multiple actions to potentiate GABAA receptors
J. Physiol.,
July 1, 2004;
558(1):
59 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leroy, P. Poisbeau, A. F. Keller, and A. Nehlig
Pharmacological plasticity of GABAA receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy
J. Physiol.,
June 1, 2004;
557(2):
473 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rusch, H. Zhong, and S. A. Forman
Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation
J. Biol. Chem.,
May 14, 2004;
279(20):
20982 - 20992.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|